0001628280-23-000082.txt : 20230103
0001628280-23-000082.hdr.sgml : 20230103
20230103161146
ACCESSION NUMBER: 0001628280-23-000082
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221230
FILED AS OF DATE: 20230103
DATE AS OF CHANGE: 20230103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Almenoff June Sherie
CENTRAL INDEX KEY: 0001492647
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37590
FILM NUMBER: 23502202
MAIL ADDRESS:
STREET 1: C/O BRAINSTORM CELL THERAPEUTICS INC.
STREET 2: 1325 AVENUE OF AMERICAS 28TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avalo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001534120
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450705648
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 410-522-8707
MAIL ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: Cerecor Inc.
DATE OF NAME CHANGE: 20111102
4
1
wf-form4_167278029177365.xml
FORM 4
X0306
4
2022-12-30
0
0001534120
Avalo Therapeutics, Inc.
AVTX
0001492647
Almenoff June Sherie
C/O AVALO THERAPEUTICS, INC.
540 GAITHER ROAD, SUITE 400
ROCKVILLE
MD
20850
1
0
0
0
Stock Option (Right to Buy)
5.0401
2022-12-30
4
A
0
410
0
A
2022-12-30
2032-12-30
Common Stock
410.0
410
D
100% of the stock option will immediately vest on the date that it is granted.
/s/ Jennifer Zoltoski, by Power of Attorney
2023-01-03